January 17, 2025 Kigali, Rwanda and San Francisco, USA

Former FDA Director Eric Karikari-Boateng joins Bio Usawa to lead its global regulatory strategy.

Bio Usawa, Inc., a leading biotechnology company committed to delivering affordable and accessible monoclonal antibody-based therapies for cancer, ophthalmic, autoimmune, and infectious diseases in Africa, has tapped the former Head of Laboratory Service at the Ghana Food and Drugs Authority, Eric Karikari-Boateng as its Head of Global Regulatory Strategy.

As Head of Global Regulatory Strategy, he will guide efforts to build next-generation regulatory capacity for ensuring timely approval and delivery of the biotech industry’s innovative, life-saving biotherapies.

Mr. Karikari-Boateng is a seasoned expert in regulatory affairs, pharmaceutical manufacturing, and quality assurance, with a proven ability to strengthen regulatory systems and enhance capacity across Africa.